Empreses emergents
2015
NOSTRUM BIODISCOVERY SLDescobriment de noves entitats químiques per a nous MoAs Projectes de descobriment de fàrmacs basats en mecanismes d'acció completament nous que condueixen a la generació de candidats a fàrmacs de primera.
Adreça
Avinguda de Josep Tarradellas 8, 08029 Barcelona, Espanya
Dades financeres
| Data | Inversors | Quantitat | Etapa | |
| Jan 2017 | 200.000 € | Seed | ||
| Sep 2016 | 450.000 € | Seed |
Resum financer
Encara no s'han registrat ingressos
Propietat CERCA
Barcelona, Spain
2005
Institut de Recerca Biomèdica (IRB Barcelona)
Contacte del Centre CERCA
CH
Cristina Horcajada
Institut de Recerca Biomèdica (IRB Barcelona)Altres accionistes públics catalans
Logotip
Logotip
Logotip
Àrees d'estat i deeptech
Estat de l'empresa i àrees de tecnologia profunda de l'empresaEstat de l'empresa
Àrea DeepTech
Informació sobre la spin-off
Descripció de l'empresa
NBD uses its own proprietary simulation technologies with structure-based simulations, artificial intelligence algorithms, and supercomputing capacity to speed up, increasing the success ratio, and profitability of the drug design process.
NBD combines powerful in-house innovative technologies with deep industrial expertise in biomolecular modelling, and leads several successful exploratory discovery projects in partnership with academia. NBD provides tailored, flexible services to help its pharma and biotech clients overcome their early discovery bottlenecks. Dedication and ethics are also key values of our company.
NBD scientific team has successfully transferred outstanding basic research technologies that have been implemented into indu
NBD combines powerful in-house innovative technologies with deep industrial expertise in biomolecular modelling, and leads several successful exploratory discovery projects in partnership with academia. NBD provides tailored, flexible services to help its pharma and biotech clients overcome their early discovery bottlenecks. Dedication and ethics are also key values of our company.
NBD scientific team has successfully transferred outstanding basic research technologies that have been implemented into indu
Descripció del producte
Technologies
Our competitive advantage relies on combining supercomputing with both proprietary and best-of-market software technologies, which we have optimized for industrial needs in biomolecular modelling.
PELE SIMULATION PLATFORM: Software for predicting the dynamic interactions between proteins and ligands.
ED/MD SUITE SIMULATION: Suite method to explore the flexibility of macromolecular targets and their use in rational drug design.
ChemistriX: Virtual compound library built with synthetic chemical knowledge with the purpose of complementing the chemistry available in current catalogues.
Third-party Technologies: In order to perform most of rational small molecule design tasks NBD is endowed, among a series of different softwares, with one of the most highly regarded platforms in the industry, the Schrodinger suite of programes.
Our competitive advantage relies on combining supercomputing with both proprietary and best-of-market software technologies, which we have optimized for industrial needs in biomolecular modelling.
PELE SIMULATION PLATFORM: Software for predicting the dynamic interactions between proteins and ligands.
ED/MD SUITE SIMULATION: Suite method to explore the flexibility of macromolecular targets and their use in rational drug design.
ChemistriX: Virtual compound library built with synthetic chemical knowledge with the purpose of complementing the chemistry available in current catalogues.
Third-party Technologies: In order to perform most of rational small molecule design tasks NBD is endowed, among a series of different softwares, with one of the most highly regarded platforms in the industry, the Schrodinger suite of programes.